Glaxo recalls flu vaccine due to potency problem
GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems.
Apr 17, 2015
0
3
GlaxoSmithKline is recalling remaining doses of a popular four-in-one flu vaccine because of effectiveness problems.
Apr 17, 2015
0
3
(AP)—GlaxoSmithKline's diet pill, alli (ow-LEYE'), is now back in most U.S. stores.
Feb 25, 2015
0
2
Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.
Dec 4, 2014
0
0
Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets.
Feb 7, 2014
0
0
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
May 22, 2013
0
0
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
May 10, 2013
0
0
British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate.
Apr 24, 2013
0
0
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Apr 17, 2013
0
0
(AP)—The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.
Apr 12, 2013
0
0
(AP) -- A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients.
Mar 20, 2012
0
0
GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's third-largest pharmaceutical company measured by revenues (after Johnson & Johnson and Pfizer).
GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks and Gaviscon.
GSK has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on the New York Stock Exchange.
This text uses material from Wikipedia, licensed under CC BY-SA